Pfizer Inc. said it ended an advanced trial of its experimental lung cancer drug figitumumab after an independent safety committee determined the treatment was unlikely to improve patients' survival.
53230
Pfizer ends trial of experimental cancer drug
1830
Pivotal study with vismodegib shows positive results in people with advanced BCC
156412
Pfizer recalls millions of birth control pills:
28502
Amgen presents data from study of the pivotal phase 3 prolia fracture trial
19593
Drug plans not sustainable
6349
First patient treated in the EffiKIR trial
107403
Clinical trials for cancer, heart disease and mental health are too small: study
75564
Pfizer pays out to doctors, researchers
147662
Galenica's kidney drug meets endpoint in trial
123726
Bristol-Myers Squibb recalls Coumadin
88639
ICON selected as Pfizer strategic partner
138078
Eli Lilly completes final phase of biotechnology expansion
45298
Pfizer pulling leukemia drug called Mylotarg from US market
79082
Pharmaceutical industry faces collapse
152738
Tamoxifen against breast cancer can save lives and reduce medical costs
16512
Nexavar in Combination with Chemotherapy Shown to Extend...
80049
Study impacts ovarian cancer treatment